CERUS CORP Long-Term Debt, Maturity, Year Five
CERUS CORP (CERS) had Long-Term Debt, Maturity, Year Five of $20.00 million as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2019-05-07
- 2019-03-31: Long-Term Debt, Maturity, Year Five $20.00M.
- 2018-09-30: Long-Term Debt, Maturity, Year Five $5.00M.
- 2018-06-30: Long-Term Debt, Maturity, Year Five $5.00M.
- 2018-03-31: Long-Term Debt, Maturity, Year Five $5.00M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2019-03-31 | $20.00M 10-Q · filed 2019-05-07 |
| 2018-09-30 | $5.00M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $5.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $5.00M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.00M 10-K · filed 2018-03-08 |
| 2017-09-30 | $8.57M 10-Q · filed 2017-11-03 |
| 2015-09-30 | $3.63M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $3.16M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.58M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.58M 10-K · filed 2015-03-16 |
| 2014-09-30 | $3.23M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $3.23M 10-Q · filed 2014-08-08 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-02 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |